Publicação de DRS Group

Happy New Year! A Warm Welcome to 2025 from Taj Pharma. 🌟🎉 As the clock strikes midnight, we at Taj Pharma extend our heartfelt wishes for a joyous and prosperous New Year 2025 to our valued colleagues, partners, and well-wishers. ✨❆🎄⋆꙳•❅*‧ ‧*❆ ₊⋆ As the clock strikes midnight, we at Taj Pharma extend our heartfelt wishes for a joyous and prosperous New Year 2025 to our valued colleagues, partners, and well-wishers. This moment of celebration is also a reflection of the resilience, dedication, and unity that defines the Taj Pharma family. Reflecting on a Year of Growth and Success The year 2024 was one of remarkable progress for Taj Pharma. We have achieved significant milestones across our pharmaceutical innovations, strengthened our partnerships globally, and expanded our product offerings to address unmet patient needs. None of this would have been possible without the unwavering support of our partners, the hard work of our employees, and the trust of our clients. Looking ahead, we aim to build on our momentum by: Innovating Patient-Centric Solutions: We are committed to advancing healthcare through cutting-edge research and world-class pharmaceutical products. ⋆꙳•̩̩͙❅*̩̩͙‧͙ ‧͙*̩̩͙❆ ͙͛ ˚₊⋆🌟 Expanding Global Reach: With operations in more than 50 countries, we plan to deepen our presence in emerging markets. Sustainable Growth: As part of our corporate responsibility, we pledge to implement eco-friendly processes and give back to communities through healthcare initiatives. #HappyNewYear2025 #HappyNewYear #NewYear

Mais um seminário ISPE, coloquem na agenda!

NutraResearch will participate in the congress "Navigating the Next Era in Pharma Packaging, Labeling, and Supply Chain Management", a key event that will gather top professionals in the European sector, including pharmaceutical firms and companies across the entire value chain. The CEO of NutraResearch, Gemma Casadevall, PhD. explains the innovations we will showcase at this important event. Looking forward to see you! #PharmaPackagingandSupplyChainConference #PPSCM #Barcelona

Fomos notícia no Diário de Coimbra! 😍 Leia aqui a notícia sobre o VI Encontro PREMIUM FARMA 💜 #redepremiumfarma #premiumfarma #aminhafarmaciaamiga #farmacias #farmaciasportugal #natalpremium #encontronatalpremium #viencontropremiumfarma #natalfarmacias #farmaceuticos

A condução de um estudo clínico pré-mercado envolve diversas etapas. No novo texto do blog da Global Research and Innovation Network - GRINN eu explico cada uma delas ;)

Happy New Year! A Warm Welcome to 2025 from Taj Pharma 🌟🎉 As the clock strikes midnight, we at Taj Pharma extend our heartfelt wishes for a joyous and prosperous New Year 2025 to our valued colleagues, partners, and well-wishers. This moment of celebration is also a reflection of the resilience, dedication, and unity that defines the Taj Pharma family. Reflecting on a Year of Growth and Success The year 2024 was one of remarkable progress for Taj Pharma. We have achieved significant milestones across our pharmaceutical innovations, strengthened our partnerships globally, and expanded our product offerings to address unmet patient needs. None of this would have been possible without the unwavering support of our partners, the hard work of our employees, and the trust of our clients. 2025: A Year of New Opportunities and Aspirations Looking ahead, we aim to build on our momentum by: Innovating Patient-Centric Solutions: We are committed to advancing healthcare through cutting-edge research and world-class pharmaceutical products. Expanding Global Reach: With operations in more than 50 countries, we plan to deepen our presence in emerging markets. Sustainable Growth: As part of our corporate responsibility, we pledge to implement eco-friendly processes and give back to communities through healthcare initiatives. कर्मण्येवाधिकारस्ते मा फलषु कदाचन। मा कर्मफलहेतुर्भूर्मा ते सङ्गोऽस्त्वकमज़्णि | ⋆꙳•❅*🎄*❆•꙳⋆ #HappyNewYear #HappyNewYear2025

Seminário extremamente relevante as #oportunidades de produção continua através da #tecnologia de matérias primas e equipamentos ! Muito feliz e confiante em fazer parte desta #revolução na produção de sólidos! IMCD Group DFE Pharma Fette Compacting America Latina #cps #directcompression #fette #fcg #fcal #solidosorais #comprimidos #processocontinuodesolidosorais

Medica and Compamed demonstrate how active the medtech scene is and that innovation is happening more than ever 🚀however we need more enablers to bring innovation into the market as regulatory requirements and funding are major challenges for companies driving innovation.

Não importa o tamanho do país mas, ter a grandeza de saber o que se propõe e buscar influenciar nas políticas publicas criando um futuro com melhores condições de saúde para todos.

This week I was at #CPHIMilan and participated in a panel discussion with industry colleagues on the European Commission’s #CriticalMedicinesAlliance (CMA), and how we can safeguard the future of medicines. The CMA aims to take steps to strengthen the supply of critical medicines in the EU – of which more than 90% are generics. To overcome medicines shortages, the underlying causes must be addressed, not just the symptoms, and that’s why we need sustainable market conditions. Three key factors must be in balance for market sustainability – to have reliable supply of medicines that are top quality, pricing must be fair. Sandoz will never compromise on quality, so to enable security of supply, pricing and reimbursement systems must be recalibrated to recognize the value of these medicines.   With the Critical Medicines Act on the horizon for 2025, I am hopeful this will be an opportunity for Europe to bring together the final pieces of this complex puzzle so every patient that needs access to these medicines can get them. Medicines for Europe (MfE) has released a vision outlining the sustainable policy frameworks needed by EU off-patent medicines manufacturers – including how we must collectively, as public and private entities, reward and invest in strategies for resilient supply and maintain solidarity across the EU. Be sure to check it out at the link below.   Thank you to my co-panelists Markus Sieger Philippe Drechsle and Roberta Pizzocaro for sharing your perspectives on this important topic. Our collaboration is key to creating a healthier future for patients and society!   MfE's vision for the European Critical Medicines Act: https://lnkd.in/etT5gjPy